Abstract
Human papillomavirus is the most common sexually transmitted disease in the United States. For the majority of affected individuals, the virus remains subclinical. However, human papillomavirus infection may result in a broad spectrum of vulvar disease including genital warts, dysplasia, and invasive carcinoma. We review the evaluation and currently available therapies to assist in patient management.
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Condylomata Acuminata / pathology
-
Condylomata Acuminata / prevention & control*
-
Condylomata Acuminata / surgery
-
Female
-
Humans
-
Papillomavirus Infections / pathology
-
Papillomavirus Infections / prevention & control*
-
Papillomavirus Infections / surgery
-
Pregnancy
-
Pregnancy Complications, Infectious / pathology
-
Pregnancy Complications, Infectious / prevention & control*
-
Pregnancy Complications, Infectious / surgery
-
Prevalence
-
Risk Factors
-
Tumor Virus Infections / pathology
-
Tumor Virus Infections / prevention & control*
-
Tumor Virus Infections / surgery
-
Uterine Cervical Diseases / pathology
-
Uterine Cervical Diseases / prevention & control
-
Uterine Cervical Diseases / surgery
-
Virus Latency
-
Vulvar Neoplasms / pathology
-
Vulvar Neoplasms / prevention & control*
-
Vulvar Neoplasms / surgery